Hæmolytisk anæmi som komplikation til intravenøs indgift af humant immunglobulin

Ugeskrift for Laeger

Volumn 173, Issue 33, 2011, Pages 1963-

  Juel, Jacob ^a   Markvardsen, Lars Høj ^a   Jakobsen, Johannes ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; GUILLAIN BARRE SYNDROME; HEMOLYTIC ANEMIA; HUMAN; MALE; POLYRADICULONEUROPATHY;

AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 80053037726     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. El-Shanawany T, Sewell WA, Misbah SA et al. Current clinical uses of intravenous immunoglobulin. Clin Med 2006;6:356-9.
2. Daw Z, Padmore R, Neurath D et al. Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis. Transfusion 2008;48:1598-601.
3. Valent P, Lechner K. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr 2008;120:136-51.
4. Kahwaji J, Barker E, Pepkowitz S et al. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Alin J Am Soc Nephrol 2009;4:1993-7.
5. http://www.medicin.dk (6. maj 2010).